언어 선택

BDNF

BDNF 분자 정보

영어 이름	Brain-derived neurotrophic factor	시판 약물 수	0
임상 약물 수	8	표적 별명	Brain-Derived Neurotrophic Factor，Abrineurin，ANON2，Brain Derived Neurotrophic Factor，BULN2，ProBDNF，Neurotrophin
최고 연구 개발 단계	Phase 3 Clinical

영어 이름	Brain-derived neurotrophic factor
표적 별명	Brain-Derived Neurotrophic Factor，Abrineurin，ANON2，Brain Derived Neurotrophic Factor，BULN2，ProBDNF，Neurotrophin
시판 약물 수	0
임상 약물 수	8
최고 연구 개발 단계	Phase 3 Clinical

BDNF 제품 목록

속성
Protein (4)
제품 라이브러리
온라인 (4)
종
Human (4)
태그
Tag Free (4)
마커
Unconjugated (4)

제품 번호	종	발현 시스템	제품 설명
BDF-H5116	Human	E. coli	Human BDNF / Abrineurin Protein (E. coli), premium grade
BDF-H5117	Human	E. coli	Human BDNF / Abrineurin Protein (E. coli), Research Grade
BDF-H5219	Human	HEK293	Human BDNF / Abrineurin Protein (HEK293), premium grade
GMP-BDFH15	Human	E. coli	GMP Human BDNF Protein (E. coli)

총 수량4

BDNF분자 배경

Brain-derived neurotrophic factor (BDNF) along with nerve growth factor (NGF), neurotrophin-3 (NT-3), and neurotrophin-4/5 (NT-4/5) are members of the neurotrophin family of trophic factors. The neurotrophins play essential roles in the development, survival, and function of a wide range of neurons in both the peripheral and central nervous systems. The neurotrophins interact with two cell surface receptors, the low affinity P75 receptor and the Trk family of high affinity tyrosine kinase receptors. NGF preferentially binds TrkA, BDNF and NT4/5 bind TrkB, and NT-3 binds TrkC (and TrkA to a lesser extent).

BDNF분자 별명

BDNF,ANON2,BULN2,Abrineurin

임상 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	적응증	임상 시험
Tetramethylpyrazine Nitrone		Phase 3 Clinical	Jinan University	Amyotrophic Lateral Sclerosis; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Ischemic Stroke	상세
JS1-1-01	JS1-1-01	Phase 3 Clinical	Tianjin Tasly Pharmaceutical Co Ltd	Depression; Depressive Disorder; Depressive Disorder, Major	상세
ACT-01	ACT-01; OCS-05; BN-201; G-79	Phase 2 Clinical	Promius Pharma	Keratosis, Actinic; Optic Neuritis	상세
Aldifen	MP101; NSC-1532; MP-101	Phase 2 Clinical	Mitochon Pharmaceuticals	Amyotrophic Lateral Sclerosis; Huntington Disease; Multiple Sclerosis	상세
ALTO-100	ALTO-100	Phase 2 Clinical	Alto Neuroscience Inc	Bipolar I Disorder; Bipolar II Disorder; Depressive Disorder, Major; Stress Disorders, Post-Traumatic	상세
AC-102	AC-102	Phase 2 Clinical	AudioCure Pharma GmbH	Hearing Loss, Sensorineural; Hearing Loss, Sudden; Tinnitus	상세
Laquinimod Sodium	TV-5600; ABR-215062; SAIK-MS	Phase 1 Clinical	Active Biotech Ab	Arthritis; Crohn Disease; Eye Diseases; Huntington Disease; Lupus Nephritis; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Uveitis	상세
AAV2-BDNF gene therapy (University Of California San Diego)		Phase 1 Clinical	University Of California San Diego	Alzheimer Disease; Cognitive Dysfunction	상세